Formulation of PPAR-gamma agonist as surface modified PLGA nanoparticles for non-invasive treatment of diabetic retinopathy: in vitro and in vivo evidences

Diabetic retinopathy is one of the worst complications of diabetes and it is treated by invasive method. We prepared a surface modified poly (D, L-lactide-co-glycolide) i.e. PLGA nanoparticles for delivery of pioglitazone-a peroxisome proliferator-activated receptor-gamma agonist to posterior segmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Laddha, Umesh D., Kshirsagar, Sanjay J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432955/
https://www.ncbi.nlm.nih.gov/pubmed/32832706
http://dx.doi.org/10.1016/j.heliyon.2020.e04589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432955/
https://www.ncbi.nlm.nih.gov/pubmed/32832706
http://dx.doi.org/10.1016/j.heliyon.2020.e04589

Ejemplares similares